Details for Patent: 6,613,308

Summary for Patent: 6,613,308

Title:	Pulmonary delivery in treating disorders of the central nervous system
Abstract:	A method for treating a disorder of the central nervous system includes administering to the respiratory tract of a patient a drug which is delivered to the pulmonary system, for instance to the alveoli or the deep lung. The drug is administered at a dose which is at least about two-fold less than the dose required by oral administration. Particles that include the drug can be employed. Preferred particles have a tap density of less than about 0.4 g/cm.sup.3. In addition to the medicament, the particles can include other materials such as, for example, phospholipids, amino acids, combinations thereof and others.
Inventor(s):	Bartus; Raymond T. (Sudbury, MA), Emerich; Dwaine F. (Cranston, RI)
Assignee:	Advanced Inhalation Research, Inc. (Cambridge, MA)
Application Number:	09/877,734
Patent Claim Types: see list of patent claims	Use; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 6,613,308

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 6,613,308

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2001291122
Australia	9112201
Canada	2421974
Cyprus	1118851